Immunoassay Market By Product (Reagents and Kits, Analyzers), By Technology (ELISA, Chemiluminescence Immunoassay, Immunofluorescence assay, Rapid Test, ELISpot, Western Blotting, Others) By Specimen (Infectious Diseases, Endocrinology, Oncology, Bone and Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others) By End user (Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Blood Banks, Research and Academic Laboratories, Home Care Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Immunoassay Market
The immunoassay market was valued at $35.0 billion in 2023 and is projected to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.
Immunoassay is a bioanalytical method that detects and quantifies the presence of proteins or antigens in a sample. The basic principle of immunoassay relies on the interaction between an antibody and a target molecule, which results in the generation of a quantifiable signal, such as fluorescence or color change. The method finds applications in pharmaceutical research, medical diagnostics, and environmental monitoring. The high specificity & sensitivity of the method is pivotal in monitoring drug levels, diagnosing diseases, screening for infectious agents, and detecting biomarkers.
Rise in the prevalence of infectious and chronic diseases is a significant driver of the immunoassay market. In addition, surge in investments in the pharmaceutical & biotechnology infrastructure has led to the expansion in infrastructure, thereby boosting the demand for immunoassay components for diverse purposes such as clinical trials, biomarker analysis, and drug discovery. Trends in the immunoassay market evolve constantly, enhancing the sensitivity and specificity of the tests. The integration of robotics and automation is acquiring traction in the market as it is enhancing productivity and helping to reduce human error in the laboratories.
However, procuring reliable instruments and authentic samples to critical for obtaining successful results. The acquisition of such trustworthy components is a challenging task owing to less retailers in the industry, thereby restraining the development of the immunoassay market. On the contrary, manufacturers of immunoassay systems strive to introduce innovative products, thereby presenting lucrative opportunities for market development. Next generation of immunoassay systems is projected to leverage the benefits of microfluidics and nanotechnology for achieving instant & accurate results.
Segment Review
The immunoassay market is segmented into product, technology, specimen, end user, and region. On the basis of product, the market is bifurcated into reagents & kits and analyzers. As per technology, it is classified into ELISA, chemiluminescence immunoassay, immunofluorescence assay, rapid test, ELISpot, western blotting, and others. According to specimen, it is categorized into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, and others. By end user, it is divided into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnology companies, blood banks, research & academic laboratories, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
As per technology, the ELISA segment generated the highest revenue in 2023.
According to specimen, the blood screening segment was the highest shareholder in 2023.
By end user, the hospitals & clinics segment acquired high market stakes in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players operating in the global immunoassay market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers, DiaSorin S.p.A., Sysmex Corporation, BioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Product
Reagents and Kits
Analyzers
By Technology
ELISA
Chemiluminescence Immunoassay
Immunofluorescence assay
Rapid Test
ELISpot
Western Blotting
Others
By Specimen
Infectious Diseases
Endocrinology
Oncology
Bone and Mineral Disorders
Cardiology
Blood Screening
Autoimmune Disorders
Allergy Diagnostics
Toxicology
Newborn Screening
Others
By End User
Hospitals and Clinics
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Blood Banks
Research and Academic Laboratories
Home Care Settings
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Abbott Laboratories
Siemens Healthineers
DiaSorin S.p.A.
Sysmex Corporation
BioMerieux SA
Ortho Clinical Diagnostics
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Merck kGaA
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: IMMUNOASSAY MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Reagents And Kits
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Analyzers
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: IMMUNOASSAY MARKET, BY TECHNOLOGY
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Technology
- 5.2. ELISA
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Chemiluminescence Immunoassay
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Immunofluorescence Assay
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Rapid Test
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. ELISpot
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- 5.7. Western Blotting
- 5.7.1. Key Market Trends, Growth Factors and Opportunities
- 5.7.2. Market Size and Forecast, By Region
- 5.7.3. Market Share Analysis, By Country
- 5.8. Others
- 5.8.1. Key Market Trends, Growth Factors and Opportunities
- 5.8.2. Market Size and Forecast, By Region
- 5.8.3. Market Share Analysis, By Country
- CHAPTER 6: IMMUNOASSAY MARKET, BY SPECIMEN
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Specimen
- 6.2. Infectious Diseases
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Endocrinology
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Oncology
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Bone And Mineral Disorders
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. Cardiology
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- 6.7. Blood Screening
- 6.7.1. Key Market Trends, Growth Factors and Opportunities
- 6.7.2. Market Size and Forecast, By Region
- 6.7.3. Market Share Analysis, By Country
- 6.8. Autoimmune Disorders
- 6.8.1. Key Market Trends, Growth Factors and Opportunities
- 6.8.2. Market Size and Forecast, By Region
- 6.8.3. Market Share Analysis, By Country
- 6.9. Allergy Diagnostics
- 6.9.1. Key Market Trends, Growth Factors and Opportunities
- 6.9.2. Market Size and Forecast, By Region
- 6.9.3. Market Share Analysis, By Country
- 6.10. Toxicology
- 6.10.1. Key Market Trends, Growth Factors and Opportunities
- 6.10.2. Market Size and Forecast, By Region
- 6.10.3. Market Share Analysis, By Country
- 6.11. Newborn Screening
- 6.11.1. Key Market Trends, Growth Factors and Opportunities
- 6.11.2. Market Size and Forecast, By Region
- 6.11.3. Market Share Analysis, By Country
- 6.12. Others
- 6.12.1. Key Market Trends, Growth Factors and Opportunities
- 6.12.2. Market Size and Forecast, By Region
- 6.12.3. Market Share Analysis, By Country
- CHAPTER 7: IMMUNOASSAY MARKET, BY END USER
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
- 7.2. Hospitals And Clinics
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
- 7.3. Clinical Laboratories
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
- 7.4. Pharmaceutical And Biotechnology Companies
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
- 7.5. Blood Banks
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
- 7.6. Research And Academic Laboratories
- 7.6.1. Key Market Trends, Growth Factors and Opportunities
- 7.6.2. Market Size and Forecast, By Region
- 7.6.3. Market Share Analysis, By Country
- 7.7. Home Care Settings
- 7.7.1. Key Market Trends, Growth Factors and Opportunities
- 7.7.2. Market Size and Forecast, By Region
- 7.7.3. Market Share Analysis, By Country
- CHAPTER 8: IMMUNOASSAY MARKET, BY REGION
- 8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
- 8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Technology
- 8.2.4. Market Size and Forecast, By Specimen
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Immunoassay Market
- 8.2.7.1. Market Size and Forecast, By Product
- 8.2.7.2. Market Size and Forecast, By Technology
- 8.2.7.3. Market Size and Forecast, By Specimen
- 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Immunoassay Market
- 8.2.8.1. Market Size and Forecast, By Product
- 8.2.8.2. Market Size and Forecast, By Technology
- 8.2.8.3. Market Size and Forecast, By Specimen
- 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Immunoassay Market
- 8.2.9.1. Market Size and Forecast, By Product
- 8.2.9.2. Market Size and Forecast, By Technology
- 8.2.9.3. Market Size and Forecast, By Specimen
- 8.2.9.4. Market Size and Forecast, By End User
- 8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Technology
- 8.3.4. Market Size and Forecast, By Specimen
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. France Immunoassay Market
- 8.3.7.1. Market Size and Forecast, By Product
- 8.3.7.2. Market Size and Forecast, By Technology
- 8.3.7.3. Market Size and Forecast, By Specimen
- 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. Germany Immunoassay Market
- 8.3.8.1. Market Size and Forecast, By Product
- 8.3.8.2. Market Size and Forecast, By Technology
- 8.3.8.3. Market Size and Forecast, By Specimen
- 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. Italy Immunoassay Market
- 8.3.9.1. Market Size and Forecast, By Product
- 8.3.9.2. Market Size and Forecast, By Technology
- 8.3.9.3. Market Size and Forecast, By Specimen
- 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Spain Immunoassay Market
- 8.3.10.1. Market Size and Forecast, By Product
- 8.3.10.2. Market Size and Forecast, By Technology
- 8.3.10.3. Market Size and Forecast, By Specimen
- 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. UK Immunoassay Market
- 8.3.11.1. Market Size and Forecast, By Product
- 8.3.11.2. Market Size and Forecast, By Technology
- 8.3.11.3. Market Size and Forecast, By Specimen
- 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest Of Europe Immunoassay Market
- 8.3.12.1. Market Size and Forecast, By Product
- 8.3.12.2. Market Size and Forecast, By Technology
- 8.3.12.3. Market Size and Forecast, By Specimen
- 8.3.12.4. Market Size and Forecast, By End User
- 8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Technology
- 8.4.4. Market Size and Forecast, By Specimen
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. China Immunoassay Market
- 8.4.7.1. Market Size and Forecast, By Product
- 8.4.7.2. Market Size and Forecast, By Technology
- 8.4.7.3. Market Size and Forecast, By Specimen
- 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. Japan Immunoassay Market
- 8.4.8.1. Market Size and Forecast, By Product
- 8.4.8.2. Market Size and Forecast, By Technology
- 8.4.8.3. Market Size and Forecast, By Specimen
- 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. India Immunoassay Market
- 8.4.9.1. Market Size and Forecast, By Product
- 8.4.9.2. Market Size and Forecast, By Technology
- 8.4.9.3. Market Size and Forecast, By Specimen
- 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. South Korea Immunoassay Market
- 8.4.10.1. Market Size and Forecast, By Product
- 8.4.10.2. Market Size and Forecast, By Technology
- 8.4.10.3. Market Size and Forecast, By Specimen
- 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. Australia Immunoassay Market
- 8.4.11.1. Market Size and Forecast, By Product
- 8.4.11.2. Market Size and Forecast, By Technology
- 8.4.11.3. Market Size and Forecast, By Specimen
- 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Immunoassay Market
- 8.4.12.1. Market Size and Forecast, By Product
- 8.4.12.2. Market Size and Forecast, By Technology
- 8.4.12.3. Market Size and Forecast, By Specimen
- 8.4.12.4. Market Size and Forecast, By End User
- 8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Technology
- 8.5.4. Market Size and Forecast, By Specimen
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Immunoassay Market
- 8.5.7.1. Market Size and Forecast, By Product
- 8.5.7.2. Market Size and Forecast, By Technology
- 8.5.7.3. Market Size and Forecast, By Specimen
- 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. South Africa Immunoassay Market
- 8.5.8.1. Market Size and Forecast, By Product
- 8.5.8.2. Market Size and Forecast, By Technology
- 8.5.8.3. Market Size and Forecast, By Specimen
- 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. Saudi Arabia Immunoassay Market
- 8.5.9.1. Market Size and Forecast, By Product
- 8.5.9.2. Market Size and Forecast, By Technology
- 8.5.9.3. Market Size and Forecast, By Specimen
- 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. Rest of LAMEA Immunoassay Market
- 8.5.10.1. Market Size and Forecast, By Product
- 8.5.10.2. Market Size and Forecast, By Technology
- 8.5.10.3. Market Size and Forecast, By Specimen
- 8.5.10.4. Market Size and Forecast, By End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top Winning Strategies
- 9.3. Product Mapping Of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Top Player Positioning, 2023
- CHAPTER 10: COMPANY PROFILES
- 10.1. F. Hoffmann-La Roche Ltd.
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
- 10.2. Danaher Corporation
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
- 10.3. Abbott Laboratories
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
- 10.4. Siemens Healthineers
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
- 10.5. DiaSorin S.p.A.
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
- 10.6. Sysmex Corporation
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
- 10.7. BioMerieux SA
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
- 10.8. Ortho Clinical Diagnostics
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
- 10.9. Thermo Fisher Scientific, Inc.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
- 10.10. Becton, Dickinson And Company
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments
- 10.11. Merck KGaA
- 10.11.1. Company Overview
- 10.11.2. Key Executives
- 10.11.3. Company Snapshot
- 10.11.4. Operating Business Segments
- 10.11.5. Product Portfolio
- 10.11.6. Business Performance
- 10.11.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. IMMUNOASSAY MARKET FOR REAGENTS AND KITS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. IMMUNOASSAY MARKET FOR ANALYZERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 5. IMMUNOASSAY MARKET FOR ELISA, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. IMMUNOASSAY MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. IMMUNOASSAY MARKET FOR IMMUNOFLUORESCENCE ASSAY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. IMMUNOASSAY MARKET FOR RAPID TEST, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. IMMUNOASSAY MARKET FOR ELISPOT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. IMMUNOASSAY MARKET FOR WESTERN BLOTTING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. IMMUNOASSAY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. GLOBAL IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 13. IMMUNOASSAY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. IMMUNOASSAY MARKET FOR ENDOCRINOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. IMMUNOASSAY MARKET FOR ONCOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. IMMUNOASSAY MARKET FOR BONE AND MINERAL DISORDERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. IMMUNOASSAY MARKET FOR CARDIOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 18. IMMUNOASSAY MARKET FOR BLOOD SCREENING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 19. IMMUNOASSAY MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 20. IMMUNOASSAY MARKET FOR ALLERGY DIAGNOSTICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 21. IMMUNOASSAY MARKET FOR TOXICOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 22. IMMUNOASSAY MARKET FOR NEWBORN SCREENING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 23. IMMUNOASSAY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 24. GLOBAL IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. IMMUNOASSAY MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 26. IMMUNOASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 27. IMMUNOASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 28. IMMUNOASSAY MARKET FOR BLOOD BANKS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 29. IMMUNOASSAY MARKET FOR RESEARCH AND ACADEMIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 30. IMMUNOASSAY MARKET FOR HOME CARE SETTINGS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 31. IMMUNOASSAY MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 32. NORTH AMERICA IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 33. NORTH AMERICA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 34. NORTH AMERICA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 35. NORTH AMERICA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 36. NORTH AMERICA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. U.S. IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 38. U.S. IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 39. U.S. IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 40. U.S. IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. CANADA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 42. CANADA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 43. CANADA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 44. CANADA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. MEXICO IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 46. MEXICO IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 47. MEXICO IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 48. MEXICO IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 49. EUROPE IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 50. EUROPE IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 51. EUROPE IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 52. EUROPE IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 53. EUROPE IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. FRANCE IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 55. FRANCE IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 56. FRANCE IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 57. FRANCE IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. GERMANY IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 59. GERMANY IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 60. GERMANY IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 61. GERMANY IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 62. ITALY IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 63. ITALY IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 64. ITALY IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 65. ITALY IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. SPAIN IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 67. SPAIN IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 68. SPAIN IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 69. SPAIN IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. UK IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 71. UK IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 72. UK IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 73. UK IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 74. REST OF EUROPE IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 75. REST OF EUROPE IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 76. REST OF EUROPE IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 77. REST OF EUROPE IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 78. ASIA-PACIFIC IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 79. ASIA-PACIFIC IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 80. ASIA-PACIFIC IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 81. ASIA-PACIFIC IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 82. ASIA-PACIFIC IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. CHINA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 84. CHINA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 85. CHINA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 86. CHINA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 87. JAPAN IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 88. JAPAN IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 89. JAPAN IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 90. JAPAN IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 91. INDIA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 92. INDIA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 93. INDIA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 94. INDIA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 95. SOUTH KOREA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 96. SOUTH KOREA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 97. SOUTH KOREA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 98. SOUTH KOREA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 99. AUSTRALIA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 100. AUSTRALIA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 101. AUSTRALIA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 102. AUSTRALIA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 103. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 104. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 105. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 106. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 107. LAMEA IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 108. LAMEA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 109. LAMEA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 110. LAMEA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 111. LAMEA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 112. BRAZIL IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 113. BRAZIL IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 114. BRAZIL IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 115. BRAZIL IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 116. SOUTH AFRICA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 117. SOUTH AFRICA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 118. SOUTH AFRICA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 119. SOUTH AFRICA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 120. SAUDI ARABIA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 121. SAUDI ARABIA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 122. SAUDI ARABIA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 123. SAUDI ARABIA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 124. REST OF LAMEA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 125. REST OF LAMEA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 126. REST OF LAMEA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
- TABLE 127. REST OF LAMEA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 128. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 129. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 130. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
- TABLE 131. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 132. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 133. DANAHER CORPORATION: KEY EXECUTIVES
- TABLE 134. DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 135. DANAHER CORPORATION: OPERATING SEGMENTS
- TABLE 136. DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 137. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 138. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 139. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 140. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 141. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 142. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 143. SIEMENS HEALTHINEERS: KEY EXECUTIVES
- TABLE 144. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
- TABLE 145. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
- TABLE 146. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
- TABLE 147. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 148. DIASORIN S.P.A.: KEY EXECUTIVES
- TABLE 149. DIASORIN S.P.A.: COMPANY SNAPSHOT
- TABLE 150. DIASORIN S.P.A.: OPERATING SEGMENTS
- TABLE 151. DIASORIN S.P.A.: PRODUCT PORTFOLIO
- TABLE 152. DIASORIN S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 153. SYSMEX CORPORATION: KEY EXECUTIVES
- TABLE 154. SYSMEX CORPORATION: COMPANY SNAPSHOT
- TABLE 155. SYSMEX CORPORATION: OPERATING SEGMENTS
- TABLE 156. SYSMEX CORPORATION: PRODUCT PORTFOLIO
- TABLE 157. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 158. BIOMERIEUX SA: KEY EXECUTIVES
- TABLE 159. BIOMERIEUX SA: COMPANY SNAPSHOT
- TABLE 160. BIOMERIEUX SA: OPERATING SEGMENTS
- TABLE 161. BIOMERIEUX SA: PRODUCT PORTFOLIO
- TABLE 162. BIOMERIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 163. ORTHO CLINICAL DIAGNOSTICS: KEY EXECUTIVES
- TABLE 164. ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
- TABLE 165. ORTHO CLINICAL DIAGNOSTICS: OPERATING SEGMENTS
- TABLE 166. ORTHO CLINICAL DIAGNOSTICS: PRODUCT PORTFOLIO
- TABLE 167. ORTHO CLINICAL DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 168. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
- TABLE 169. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
- TABLE 170. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
- TABLE 171. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
- TABLE 172. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 173. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 174. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 175. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 176. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 177. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 178. MERCK KGAA: KEY EXECUTIVES
- TABLE 179. MERCK KGAA: COMPANY SNAPSHOT
- TABLE 180. MERCK KGAA: OPERATING SEGMENTS
- TABLE 181. MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 182. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL IMMUNOASSAY MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF IMMUNOASSAY MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN IMMUNOASSAY MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALIMMUNOASSAY MARKET
- FIGURE 10. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. IMMUNOASSAY MARKET FOR REAGENTS AND KITS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. IMMUNOASSAY MARKET FOR ANALYZERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY TECHNOLOGY
- FIGURE 14. IMMUNOASSAY MARKET FOR ELISA, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. IMMUNOASSAY MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. IMMUNOASSAY MARKET FOR IMMUNOFLUORESCENCE ASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. IMMUNOASSAY MARKET FOR RAPID TEST, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. IMMUNOASSAY MARKET FOR ELISPOT, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. IMMUNOASSAY MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. IMMUNOASSAY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY SPECIMEN
- FIGURE 22. IMMUNOASSAY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. IMMUNOASSAY MARKET FOR
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook